These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20416986)

  • 21. Acute treatment of migraine: established and emerging therapies.
    Rapoport AM
    Headache; 2012 Oct; 52 Suppl 2():60-4. PubMed ID: 23030533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Migraine headaches: treatment limitations and opportunities.
    Kaniecki RG; Hutchinson S
    Postgrad Med; 2006 Apr; Spec No():14-9. PubMed ID: 17957856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triptans vs other drugs for acute migraine.
    Steiner T
    Headache; 2008 Oct; 48(9):1378-9. PubMed ID: 18793208
    [No Abstract]   [Full Text] [Related]  

  • 24. [Migraine treatment].
    Noth J
    Dtsch Med Wochenschr; 2000 Mar; 125(13):408. PubMed ID: 10778403
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
    Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
    Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.
    Tepper SJ; Cleves C
    Curr Opin Investig Drugs; 2009 Jul; 10(7):711-20. PubMed ID: 19579177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al.
    Burstein R; Jakubowski M
    Cephalalgia; 2009 Oct; 29(10):1019-20. PubMed ID: 19366354
    [No Abstract]   [Full Text] [Related]  

  • 28. Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine.
    Tfelt-Hansen P
    Headache; 2011 Jan; 51(1):118-23. PubMed ID: 21070229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen.
    Kornblau DH
    Neurology; 2007 Apr; 68(17):1441. PubMed ID: 17452599
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological treatment of migraine during pregnancy and breastfeeding.
    Amundsen S; Nordeng H; Nezvalová-Henriksen K; Stovner LJ; Spigset O
    Nat Rev Neurol; 2015 Apr; 11(4):209-19. PubMed ID: 25776823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of menstrual migraine: evidence-based review.
    Tepper SJ
    Manag Care; 2007 Jul; 16(7 Suppl 7):10-4; discussion 15-7. PubMed ID: 17927087
    [No Abstract]   [Full Text] [Related]  

  • 32. [Something's moving in chronic migraine].
    Cernuda-Morollón E; Pascual J
    Rev Neurol; 2014 Jan; 58(1):1-3. PubMed ID: 24343534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
    Cady RK; Banks J; Jones BA; Campbell J
    Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs for migraine.
    Treat Guidel Med Lett; 2011 Feb; 9(102):7-12; quiz 14. PubMed ID: 21304447
    [No Abstract]   [Full Text] [Related]  

  • 35. [Migraine: a disease, not a symptom].
    Henry P
    Rev Prat; 2002 Jan; 52(1):5-7. PubMed ID: 11852766
    [No Abstract]   [Full Text] [Related]  

  • 36. Migraine.
    Ashina M
    N Engl J Med; 2020 Nov; 383(19):1866-1876. PubMed ID: 33211930
    [No Abstract]   [Full Text] [Related]  

  • 37. Migraine prophylaxis: who, why, and how.
    Loj J; Solomon GD
    Cleve Clin J Med; 2006 Sep; 73(9):793-4, 797, 800-1 passim. PubMed ID: 16970133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
    Dodick DW; Kost J; Assaid C; Lines C; Ho TW
    Cephalalgia; 2011 Feb; 31(3):296-300. PubMed ID: 20937606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rates and predictors of starting a triptan: results from the American Migraine Prevalence and Prevention Study.
    Bigal ME; Buse DC; Chen YT; Golden W; Serrano D; Chu MK; Lipton RB
    Headache; 2010 Oct; 50(9):1440-8. PubMed ID: 20533956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug safety in acute migraine treatment.
    Tajti J; Majláth Z; Szok D; Csáti A; Vécsei L
    Expert Opin Drug Saf; 2015 Jun; 14(6):891-909. PubMed ID: 25773005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.